血管瘤和脉管畸形的诊疗进展(2020—2021)

The development of hemangioma and vascular malformation (2020—2021)

该文对2020—2021年血管瘤和脉管畸形领域的文献进行综述,主要的进展:疾病的新概念、新认识的提出,包括良性新生儿血管瘤病、迟发增殖性先天性血管瘤、PIK3CA相关疾病;血管瘤与脉管畸形药物治疗的疗效比较,包括传统口服、外用药及近年备受关注的靶向治疗;物理治疗的疗效,包括光动力治疗和"博来霉素载药泡沫"疗法。随着血管瘤和脉管畸形领域研究的深入,相应问题和挑战也越多,更需把握现有的科研方向,进行更多有益的探索。

This paper summarizes the latest research on hemangioma and vascular malformation from 2020 to 2021.The main advances include new concepts and understanding of diseases:benign neonatal hemangiomatosis,tardive expansion congenital hemangioma,and PIK3CA-related overgrowth spectrum;comparison of therapeutic effects of drugs,including traditional oral,topical medication and targeted therapy which has attracted much attention in recent years;therapeutic effects of physical therapy including photodynamic and"bleomycin-polidocanol foam"therapy.With the deepening of research in the field of hemangioma and vascular malformation,there are more problems and challenges.It is more necessary to grasp the main research direction and carry out more beneficial exploration.